# Filana Therapeutics Inc. (FLNA)

Source: https://www.quantisnow.com/company/FLNA
Generated: 2026-11-15T01:16:59.296Z

- Ticker: FLNA
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- SEC CIK: 0001069530

## Latest FLNA news and filings

- 2026-11-12 21:14 UTC [SEC Form 4] [Director Quigley Jill M. was granted 53,000 stock options (SEC Form 4)](https://www.quantisnow.com/insight/director-quigley-jill-m-was-granted-53000-stock-options-sec-6788063)
- 2026-11-12 21:08 UTC [SEC Form 3] [SEC Form 3 filed by new insider Quigley Jill M.](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-quigley-jill-m-6787904)
- 2026-11-12 13:18 UTC [SEC Form 8-K] [Filana Therapeutics Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/filana-therapeutics-inc-filed-sec-form-8-k-leadership-update-regulation-6786586)
- 2026-11-11 13:00 UTC [Leadership Update] [Filana Therapeutics Names Biopharma Executive Jill M. Quigley to Board](https://www.quantisnow.com/insight/filana-therapeutics-names-biopharma-executive-jill-m-quigley-to-board-6785220)
- 2026-11-05 21:07 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Filana Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-filana-therapeutics-inc-6776324)
- 2026-11-05 13:10 UTC [SEC Form 8-K] [Filana Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/filana-therapeutics-inc-filed-sec-form-8-k-results-of-operations-6774939)
- 2026-11-05 13:00 UTC [Earnings] [Filana Therapeutics Reports Q3 2026 Financial Results and Provides Business Update](https://www.quantisnow.com/insight/filana-therapeutics-reports-q3-2026-financial-results-and-provides-business-6774875)
- 2026-10-28 12:00 UTC [Filana Therapeutics Announces Publication in Cells of Promising Preclinical Findings for Simufilam in TSC2-Deficient Cells](https://www.quantisnow.com/insight/filana-therapeutics-announces-publication-in-cells-of-promising-preclinical-findings-6760582)
- 2026-10-20 12:17 UTC [SEC Form 8-K] [SEC Form 8-K filed by Filana Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-filana-therapeutics-inc-6751602)
- 2026-10-09 12:00 UTC [Conference Announcement] [Filana Therapeutics to Participate in the 2026 Maxim Growth Summit](https://www.quantisnow.com/insight/filana-therapeutics-to-participate-in-the-2026-maxim-growth-summit-6742387)
- 2026-10-01 11:57 UTC [Insider Buy] [President & CEO Barry Richard bought $278,132 worth of shares (306,813 units at $0.91) (SEC Form 4)](https://www.quantisnow.com/insight/president-ceo-barry-richard-bought-278132-worth-of-shares-306813-6731431)
- 2026-09-30 20:03 UTC [Insider Buy] [President & CEO Barry Richard bought $78,196 worth of shares (93,091 units at $0.84) (SEC Form 4)](https://www.quantisnow.com/insight/president-ceo-barry-richard-bought-78196-worth-of-shares-93091-6730556)
- 2026-09-22 12:00 UTC [SEC Form 8-K] [Filana Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/filana-therapeutics-inc-filed-sec-form-8-k-regulation-fd-disclosure-6722433)
- 2026-09-22 12:00 UTC [Conference Announcement] [Filana Therapeutics Announces FDA Lift of Clinical Hold on Simufilam, Enabling Phase 2a Study in TSC-Related Epilepsy](https://www.quantisnow.com/insight/filana-therapeutics-announces-fda-lift-of-clinical-hold-on-simufilam-6722398)
- 2026-09-18 20:16 UTC [SEC Form 8-K] [Filana Therapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/filana-therapeutics-inc-filed-sec-form-8-k-notice-of-delisting-6720585)
- 2026-07-29 12:28 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Filana Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-filana-therapeutics-inc-6652876)
- 2026-07-29 12:15 UTC [SEC Form 8-K] [Filana Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/filana-therapeutics-inc-filed-sec-form-8-k-results-of-operations-6652864)
- 2026-07-29 12:00 UTC [Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update](https://www.quantisnow.com/insight/filana-therapeutics-reports-q2-2026-financial-results-and-provides-business-6652771)
- 2026-06-15 10:23 UTC [SEC Form 8-K] [Filana Therapeutics Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/filana-therapeutics-inc-filed-sec-form-8-k-leadership-update-submission-6601693)
- 2026-05-07 21:16 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Filana Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-filana-therapeutics-inc-6540278)
- 2026-05-07 12:10 UTC [SEC Form 8-K] [Filana Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/filana-therapeutics-inc-filed-sec-form-8-k-results-of-operations-6537711)
- 2026-05-07 12:00 UTC [Filana Therapeutics Reports Q1 2026 Financial Results and Business Update](https://www.quantisnow.com/insight/filana-therapeutics-reports-q1-2026-financial-results-and-business-update-6537592)
- 2026-05-05 12:00 UTC [Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII](https://www.quantisnow.com/insight/filana-therapeutics-presents-tsc-related-epilepsy-program-at-eilat-xviii-6530881)
- 2026-04-28 20:04 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Filana Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-filana-therapeutics-inc-6518510)
- 2026-04-28 20:01 UTC [SEC Form 8-K] [SEC Form 8-K filed by Filana Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-filana-therapeutics-inc-6518405)
- 2026-04-15 12:00 UTC [Filana Therapeutics Announces Publication in Epilepsia of Preclinical Simufilam Data](https://www.quantisnow.com/insight/filana-therapeutics-announces-publication-in-epilepsia-of-preclinical-simufilam-data-6500515)
- 2026-03-12 12:00 UTC [Filana Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results](https://www.quantisnow.com/insight/filana-therapeutics-reports-fourth-quarter-and-full-year-2025-financial-6443492)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/FLNA
- Earnings history: https://www.quantisnow.com/earnings/FLNA
- Dividend history: https://www.quantisnow.com/dividends/FLNA
- Insider transactions: https://www.quantisnow.com/insiders/FLNA
- Options chain: https://www.quantisnow.com/options/FLNA
- SEC 8-K filings only: https://www.quantisnow.com/company/FLNA/8-k
- RSS and alerts for FLNA: https://www.quantisnow.com/docs/rss-feeds.md